Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACO: Low Dose Statins, Ezetimibe and Nutraceuticals in Statin-Intolerant CAD
NCT03277079Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Oct 2017
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Therapeutic target achievement (LDL <70 mg/dL) at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT03277079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277079.